Claudio Chuaqui

2.5k total citations
26 papers, 1.4k citations indexed

About

Claudio Chuaqui is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Claudio Chuaqui has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Claudio Chuaqui's work include Computational Drug Discovery Methods (8 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Claudio Chuaqui is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Claudio Chuaqui collaborates with scholars based in United States, United Kingdom and Switzerland. Claudio Chuaqui's co-authors include Juswinder Singh, Zhan Deng, Michelle L. Lamb, Nancy Su, Qibin Su, Brian Aquila, Sharon Tentarelli, Philip B. Rawlins, Alexander W. Hird and Matthew A. Belmonte and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Nature Chemical Biology.

In The Last Decade

Claudio Chuaqui

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Chuaqui United States 17 1.0k 592 347 266 141 26 1.4k
John S. Tokarski United States 23 776 0.8× 450 0.8× 690 2.0× 438 1.6× 146 1.0× 43 2.0k
John R. Regan United States 13 997 1.0× 314 0.5× 512 1.5× 280 1.1× 83 0.6× 19 1.5k
Neil Moss United States 19 1.1k 1.1× 313 0.5× 623 1.8× 362 1.4× 87 0.6× 34 1.7k
A.E. Surgenor United Kingdom 18 1.1k 1.1× 463 0.8× 563 1.6× 189 0.7× 173 1.2× 21 1.7k
George Vielhauer United States 23 905 0.9× 234 0.4× 304 0.9× 187 0.7× 136 1.0× 33 1.4k
Tamer S. Kaoud United States 27 1.2k 1.1× 227 0.4× 468 1.3× 188 0.7× 97 0.7× 68 1.7k
Peter M.U. Ung United States 21 1.2k 1.2× 430 0.7× 118 0.3× 152 0.6× 238 1.7× 32 1.6k
Pier F. Cirillo United States 16 1.0k 1.0× 298 0.5× 777 2.2× 260 1.0× 100 0.7× 30 1.7k
Anne G. Graham United States 10 804 0.8× 267 0.5× 502 1.4× 230 0.9× 163 1.2× 16 1.3k
Prabha N. Ibrahim United States 11 1.1k 1.0× 276 0.5× 452 1.3× 263 1.0× 279 2.0× 17 1.5k

Countries citing papers authored by Claudio Chuaqui

Since Specialization
Citations

This map shows the geographic impact of Claudio Chuaqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Chuaqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Chuaqui more than expected).

Fields of papers citing papers by Claudio Chuaqui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Chuaqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Chuaqui. The network helps show where Claudio Chuaqui may publish in the future.

Co-authorship network of co-authors of Claudio Chuaqui

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Chuaqui. A scholar is included among the top collaborators of Claudio Chuaqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Chuaqui. Claudio Chuaqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kettle, Jason G., Qibin Su, Neil P. Grimster, et al.. (2017). Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205. Cancer Research. 77(13_Supplement). 979–979. 5 indexed citations
2.
Hennessy, Edward J., Claudio Chuaqui, Susan Ashton, et al.. (2016). Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation. ACS Medicinal Chemistry Letters. 7(5). 514–519. 7 indexed citations
3.
Belmonte, Matthew A., Brian Aquila, Claudio Chuaqui, et al.. (2016). Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain. Nature Chemical Biology. 12(11). 931–936. 162 indexed citations
4.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2016). Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors. ACS Medicinal Chemistry Letters. 7(12). 1118–1123. 20 indexed citations
5.
Dowling, James J., Marat Alimzhanov, Claudio Chuaqui, et al.. (2016). Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo. ACS Medicinal Chemistry Letters. 7(3). 300–305. 42 indexed citations
6.
Johannes, Jeffrey W., Claudio Chuaqui, Scott D. Cowen, et al.. (2014). Discovery of 6-aryl-azabenzimidaoles that inhibit the TBK1/IKK-ε kinases. Bioorganic & Medicinal Chemistry Letters. 24(4). 1138–1143. 13 indexed citations
7.
McCoull, William, Edward J. Hennessy, Kevin Blades, et al.. (2014). Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity. MedChemComm. 5(10). 1533–1539. 14 indexed citations
8.
Yang, Bin, Michelle L. Lamb, Tao Zhang, et al.. (2014). Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening. Journal of Medicinal Chemistry. 57(23). 9958–9970. 35 indexed citations
9.
Woessner, Richard, Geraldine Bebernitz, Kirsten Bell, et al.. (2013). Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity.. Cancer Research. 73(8_Supplement). 931–931.
10.
Dowling, James J., Marat Alimzhanov, M. Block, et al.. (2013). Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo. ACS Medicinal Chemistry Letters. 4(8). 800–805. 41 indexed citations
11.
Wu, Jiaquan, Keith Mikule, Wenxian Wang, et al.. (2013). Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1. ACS Chemical Biology. 8(10). 2201–2208. 85 indexed citations
12.
Wang, Tao, Scott D. Cowen, Audrey M. Davies, et al.. (2012). Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases. Bioorganic & Medicinal Chemistry Letters. 22(5). 2063–2069. 38 indexed citations
13.
Guckian, Kevin M., Edward Yin-Shiang Lin, Michael Y. Choi, et al.. (2009). Pyrazolone based TGFβR1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(1). 326–329. 23 indexed citations
14.
Bonafoux, D., Claudio Chuaqui, P. Ann Boriack‐Sjodin, et al.. (2008). 2-Aminoimidazoles inhibitors of TGF-β receptor 1. Bioorganic & Medicinal Chemistry Letters. 19(3). 912–916. 26 indexed citations
15.
Sun, Dongyu, Claudio Chuaqui, Zhan Deng, et al.. (2006). A Kinase‐focused Compound Collection: Compilation and Screening Strategy. Chemical Biology & Drug Design. 67(6). 385–394. 14 indexed citations
16.
Singh, Juswinder, et al.. (2005). Structural Interaction Fingerprints: A New Approach to Organizing, Mining, Analyzing, and Designing Protein–Small Molecule Complexes. Chemical Biology & Drug Design. 67(1). 5–12. 57 indexed citations
17.
Deng, Zhan, Claudio Chuaqui, & Juswinder Singh. (2005). Knowledge-Based Design of Target-Focused Libraries Using Protein−Ligand Interaction Constraints. Journal of Medicinal Chemistry. 49(2). 490–500. 54 indexed citations
18.
Chin, Darin, Claudio Chuaqui, & Joginder Singh. (2004). Integration of Virtual Screening into the Drug Discovery Process. Mini-Reviews in Medicinal Chemistry. 4(10). 1053–1065. 12 indexed citations
19.
Singh, Juswinder, Claudio Chuaqui, P. Ann Boriack‐Sjodin, et al.. (2003). Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI). Bioorganic & Medicinal Chemistry Letters. 13(24). 4355–4359. 133 indexed citations
20.
Deng, Zhan, Claudio Chuaqui, & Juswinder Singh. (2003). Structural Interaction Fingerprint (SIFt):  A Novel Method for Analyzing Three-Dimensional Protein−Ligand Binding Interactions. Journal of Medicinal Chemistry. 47(2). 337–344. 434 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Tokarski Breakdown of academic impact, for papers by John R. Regan Breakdown of academic impact, for papers by Neil Moss Breakdown of academic impact, for papers by A.E. Surgenor Breakdown of academic impact, for papers by George Vielhauer Breakdown of academic impact, for papers by Tamer S. Kaoud Breakdown of academic impact, for papers by Peter M.U. Ung Breakdown of academic impact, for papers by Pier F. Cirillo Breakdown of academic impact, for papers by Anne G. Graham Breakdown of academic impact, for papers by Prabha N. Ibrahim
Rankless by CCL
2026